首页> 外国专利> Formulation of oral pharmaceuticals dosage process for the preparation of an enteric process-coated oral drug formulation to inhibit gastric acid secretion in mammals and human beings and use of an oral pharmaceutical formulation

Formulation of oral pharmaceuticals dosage process for the preparation of an enteric process-coated oral drug formulation to inhibit gastric acid secretion in mammals and human beings and use of an oral pharmaceutical formulation

机译:制备用于抑制哺乳动物和人类中胃酸分泌的肠溶衣的口服药物制剂的口服药物制剂的配方以及口服药物制剂的用途

摘要

A new oral pharmaceutical dosage form comprising a core material that contains a proton pump inhibitor, one or more alkaline reacting compounds and optionally pharmaceutical excipients having a water soluble separating layer and an enteric coating layer. The core material as such is alkaline reacting and the separating layer between the alkaline reacting core material and the enteric coating layer is formed in situ as a water soluble salt between the alkaline reacting compound(s) and the enteric coating polymer. The invention also describes a new efficient process for the manufacture of such a dosage form comprising two functionally different layers in one manufacturing step, and its use in medicine. IMAGE
机译:一种新的口服药物剂型,其包含核心材料,所述核心材料包含质子泵抑制剂,一种或多种碱性反应化合物以及任选地具有水溶性分离层和肠溶衣层的药物赋形剂。这样的核心材料是碱性反应,并且在碱性反应的核心材料和肠溶衣层之间的分离层在碱性反应化合物和肠溶衣聚合物之间作为水溶性盐原位形成。本发明还描述了一种用于在一个制造步骤中制造包括两个功能不同层的剂型的新的有效方法,及其在医学中的用途。 <图像>

著录项

  • 公开/公告号BR9605121A

    专利类型

  • 公开/公告日1997-10-14

    原文格式PDF

  • 申请/专利权人 ASTRA AKTIEBOLAG;

    申请/专利号BR19969605121

  • 发明设计人 PER JOHAN LUNDBERG;KURT LOVGREN;

    申请日1996-02-09

  • 分类号A61K9/30;A61K31/44;A61K47/18;

  • 国家 BR

  • 入库时间 2022-08-22 03:27:37

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号